Cefdinir 300 MG Oral Capsule — RxCUI 200346
RxNorm drug concept · Semantic clinical drug
RxCUI 200346
Semantic clinical drug · SCD
● Current RxNorm concept 40 FDA products
82 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI200346
Official nameCefdinir 300 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped40
Package NDCs mapped82
Reported Medicaid activity (SDUD)848,688 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Cefdinir: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Cefdinir treats a range of common bacterial infections — strep throat, sinus infections, ear infections (mainly in kids), pneumonia, bronchitis flare-ups, and uncomplicated skin in...
- What kinds of infections does cefdinir treat?
- It depends — and this is really important to tell your doctor upfront. Cefdinir is in the cephalosporin family, which is related to penicillin. Up to about 1 in 10 people with a pe...
- Can I take cefdinir if I'm allergic to penicillin?
🕸️ Concept Web — How Cefdinir 300 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Cefdinir 300 MG Oral Capsule
RxCUI 200346 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Cefdinir
25037IN
-
Cefdinir
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Cefdinir Oral Capsule
371325SCDF -
Cefdinir Oral Product
1160602SCDG -
Cefdinir Pill
1160603SCDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Cefdinir Oral Capsule
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Cefdinir 300 MG
315595SCDC
-
Cefdinir 300 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Cefdinir 300 MG
SCDC · 315595 -
Cefdinir Oral Capsule
SCDF · 371325 -
Cefdinir Oral Product
SCDG · 1160602 -
Cefdinir Pill
SCDG · 1160603
📦 FDA Products & Package NDCs
40 products · 82 package NDCs
82 package NDCs map to RxCUI 200346 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-3160-06 | 60 CAPSULE in 1 BOTTLE (0093-3160-06) | Cefdinir | Teva Pharmaceuticals USA, Inc. | 2007-05-09 |
| 00781-2176-01 | 100 CAPSULE in 1 BOTTLE (0781-2176-01) | Cefdinir | Sandoz Inc | 2007-04-06 |
| 00781-2176-60 | 60 CAPSULE in 1 BOTTLE (0781-2176-60) | Cefdinir | Sandoz Inc | 2007-04-06 |
| 00781-2176-64 | 3 CARTON in 1 CARTON (0781-2176-64) / 1 BLISTER PACK in 1 C... | Cefdinir | Sandoz Inc | 2007-04-06 |
| 00781-2176-69 | 5 BLISTER PACK in 1 CARTON (0781-2176-69) / 10 CAPSULE in 1... | Cefdinir | Sandoz Inc | 2007-04-06 |
| 00904-7563-04 | 3 BLISTER PACK in 1 CARTON (0904-7563-04) / 10 CAPSULE in 1... | Cefdinir | Major Pharmaceuticals | 2025-10-27 |
| 42291-0043-60 | 60 CAPSULE in 1 BOTTLE (42291-043-60) | Cefdinir | AvKARE | 2024-06-13 |
| 43063-0959-14 | 14 CAPSULE in 1 BOTTLE, PLASTIC (43063-959-14) | Cefdinir | PD-Rx Pharmaceuticals, Inc. | 2024-03-12 |
| 43063-0959-20 | 20 CAPSULE in 1 BOTTLE, PLASTIC (43063-959-20) | Cefdinir | PD-Rx Pharmaceuticals, Inc. | 2019-04-01 |
| 43063-0964-14 | 14 CAPSULE in 1 BOTTLE, PLASTIC (43063-964-14) | Cefdinir | PD-Rx Pharmaceuticals, Inc. | 2019-04-05 |
| 43063-0964-20 | 20 CAPSULE in 1 BOTTLE, PLASTIC (43063-964-20) | Cefdinir | PD-Rx Pharmaceuticals, Inc. | 2019-04-10 |
| 50090-1033-00 | 10 CAPSULE in 1 BOTTLE (50090-1033-0) | Cefdinir | A-S Medication Solutions | 2019-10-09 |
| 50090-1033-01 | 20 CAPSULE in 1 BOTTLE (50090-1033-1) | Cefdinir | A-S Medication Solutions | 2014-11-28 |
| 50090-1033-02 | 14 CAPSULE in 1 BOTTLE (50090-1033-2) | Cefdinir | A-S Medication Solutions | 2019-10-09 |
| 50090-2719-00 | 10 CAPSULE in 1 BOTTLE (50090-2719-0) | Cefdinir | A-S Medication Solutions | 2019-10-04 |
| 50090-2719-01 | 20 CAPSULE in 1 BOTTLE (50090-2719-1) | Cefdinir | A-S Medication Solutions | 2016-12-20 |
| 50090-2719-02 | 14 CAPSULE in 1 BOTTLE (50090-2719-2) | Cefdinir | A-S Medication Solutions | 2016-12-20 |
| 50090-2719-03 | 30 CAPSULE in 1 BOTTLE (50090-2719-3) | Cefdinir | A-S Medication Solutions | 2017-01-06 |
| 50090-6041-00 | 10 CAPSULE in 1 BOTTLE (50090-6041-0) | Cefdinir | A-S Medication Solutions | 2022-07-13 |
| 50090-6041-01 | 20 CAPSULE in 1 BOTTLE (50090-6041-1) | Cefdinir | A-S Medication Solutions | 2022-07-13 |
| 50090-6041-02 | 14 CAPSULE in 1 BOTTLE (50090-6041-2) | Cefdinir | A-S Medication Solutions | 2022-07-13 |
| 50090-6041-03 | 30 CAPSULE in 1 BOTTLE (50090-6041-3) | Cefdinir | A-S Medication Solutions | 2022-07-13 |
| 50090-6042-00 | 20 CAPSULE in 1 BOTTLE (50090-6042-0) | Cefdinir | A-S Medication Solutions | 2022-07-13 |
| 50090-6042-01 | 14 CAPSULE in 1 BOTTLE (50090-6042-1) | Cefdinir | A-S Medication Solutions | 2023-12-13 |
| 57237-0099-60 | 60 CAPSULE in 1 BOTTLE (57237-099-60) | Cefdinir | Rising Pharma Holdings, Inc. | 2008-01-07 |
| 60687-0699-21 | 30 BLISTER PACK in 1 CARTON (60687-699-21) / 1 CAPSULE in 1... | Cefdinir | American Health Packaging | 2023-06-26 |
| 63187-0989-14 | 14 CAPSULE in 1 BOTTLE (63187-989-14) | Cefdinir | Proficient Rx LP | 2018-04-02 |
| 63187-0989-20 | 20 CAPSULE in 1 BOTTLE (63187-989-20) | Cefdinir | Proficient Rx LP | 2018-04-02 |
| 63629-5101-01 | 10 CAPSULE in 1 BOTTLE (63629-5101-1) | Cefdinir | Bryant Ranch Prepack | 2025-04-07 |
| 63629-8968-01 | 20 CAPSULE in 1 BOTTLE (63629-8968-1) | Cefdinir | Bryant Ranch Prepack | 2022-08-01 |
| 65862-0177-05 | 500 CAPSULE in 1 BOTTLE (65862-177-05) | Cefdinir | Aurobindo Pharma Limited | 2008-01-07 |
| 65862-0177-30 | 30 CAPSULE in 1 BOTTLE (65862-177-30) | Cefdinir | Aurobindo Pharma Limited | 2008-01-07 |
| 65862-0177-60 | 60 CAPSULE in 1 BOTTLE (65862-177-60) | Cefdinir | Aurobindo Pharma Limited | 2008-01-07 |
| 67296-1448-01 | 10 CAPSULE in 1 BOTTLE (67296-1448-1) | Cefdinir | Redpharm Drug, Inc. | 2021-02-20 |
| 67296-1448-02 | 20 CAPSULE in 1 BOTTLE (67296-1448-2) | Cefdinir | Redpharm Drug, Inc. | 2021-02-20 |
| 67877-0543-01 | 100 CAPSULE in 1 BOTTLE (67877-543-01) | Cefdinir | Ascend Laboratories, LLC | 2021-02-20 |
| 67877-0543-38 | 10 BLISTER PACK in 1 CARTON (67877-543-38) / 10 CAPSULE in... | Cefdinir | Ascend Laboratories, LLC | 2021-02-20 |
| 67877-0543-60 | 60 CAPSULE in 1 BOTTLE (67877-543-60) | Cefdinir | Ascend Laboratories, LLC | 2021-02-20 |
| 68001-0362-06 | 60 CAPSULE in 1 BOTTLE (68001-362-06) | Cefdinir | BluePoint Laboratories | 2018-08-01 |
| 68071-2401-02 | 2 CAPSULE in 1 BOTTLE (68071-2401-2) | Cefdinir | NuCare Pharmaceuticals,Inc. | 2021-05-13 |
| 68071-2503-02 | 20 CAPSULE in 1 BOTTLE (68071-2503-2) | Cefdinir | NuCare Pharmaceuticals,Inc. | 2021-02-20 |
| 68071-2503-03 | 30 CAPSULE in 1 BOTTLE (68071-2503-3) | Cefdinir | NuCare Pharmaceuticals,Inc. | 2025-01-14 |
| 68071-3998-02 | 2 CAPSULE in 1 BOTTLE (68071-3998-2) | Cefdinir | NuCare Pharmaceuticals, Inc. | 2026-05-06 |
| 68071-4007-02 | 20 CAPSULE in 1 BOTTLE (68071-4007-2) | Cefdinir | NuCare Pharmaceuticals,Inc. | 2017-07-19 |
| 68071-4007-03 | 30 CAPSULE in 1 BOTTLE (68071-4007-3) | Cefdinir | NuCare Pharmaceuticals,Inc. | 2017-07-19 |
| 68071-4007-07 | 14 CAPSULE in 1 BOTTLE (68071-4007-7) | Cefdinir | NuCare Pharmaceuticals,Inc. | 2017-07-19 |
| 68071-4856-02 | 20 CAPSULE in 1 BOTTLE (68071-4856-2) | Cefdinir | NuCare Pharmaceuticals,Inc. | 2019-04-17 |
| 68071-4856-07 | 14 CAPSULE in 1 BOTTLE (68071-4856-7) | Cefdinir | NuCare Pharmaceuticals,Inc. | 2019-04-17 |
| 68071-4946-02 | 2 CAPSULE in 1 BOTTLE (68071-4946-2) | Cefdinir | NuCare Pharmaceuticals,Inc. | 2019-06-26 |
| 68071-5145-02 | 20 CAPSULE in 1 BOTTLE (68071-5145-2) | Cefdinir | NuCare Pharmaceuticals,Inc. | 2020-01-08 |
Observed labelers:
Proficient Rx LP (14) ·
A-S Medication Solutions (13) ·
NuCare Pharmaceuticals,Inc. (11) ·
PD-Rx Pharmaceuticals, Inc. (8) ·
REMEDYREPACK INC. (6) ·
Sandoz Inc (4)
· +16 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.4581
Range $0.4581–$0.4581
· middle 50% $0.4581–$0.4581
· 8 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.